Citigroup’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-3
Closed -$81 4719
2022
Q4
$81 Sell
3
-20
-87% -$540 ﹤0.01% 4838
2022
Q3
$1K Sell
23
-41
-64% -$1.78K ﹤0.01% 4771
2022
Q2
$2K Sell
64
-214
-77% -$6.69K ﹤0.01% 5046
2022
Q1
$15K Sell
278
-23
-8% -$1.24K ﹤0.01% 4541
2021
Q4
$89K Buy
301
+176
+141% +$52K ﹤0.01% 4024
2021
Q3
$48K Buy
125
+42
+51% +$16.1K ﹤0.01% 4005
2021
Q2
$43K Buy
83
+35
+73% +$18.1K ﹤0.01% 4224
2021
Q1
$27K Sell
48
-28
-37% -$15.8K ﹤0.01% 4405
2020
Q4
$52K Buy
+76
New +$52K ﹤0.01% 4072